Table 2 Comparison of clinical characteristics between sessile serrated adenomas/polyps without and with dysplasia or adenocarcinoma groups.

From: Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population: A Korean Association for the Study of Intestinal Diseases (KASID) multicenter study

Variables

Frequency (%) or mean ± SD

P value

SSA/POs (n = 370)

SSA/PDAs (n = 162)

Patient factors

  Age (years) [mean ± SD] (range)

57.8 ± 12.4 (23.0–85.0)

58.6 ± 12.7 (31.0–90.0)

0.475

  Sex

  

0.503

    Male

210 (56.8)

97 (59.9)

 

    Female

160 (43.2)

65 (40.1)

 

  BMI (n = 499) [mean ± SD] (range)

24.3 ± 4.1 (14.3–55.0)

23.5 ± 3.2 (14.4–39.0)

0.019

  Alcohol (n = 498)

  

0.629

    No

202 (59.6)

95 (59.7)

 

    Yes

137 (40.4)

64 (40.3)

 

    Smoking (n = 500)

  

0.718

    No

226 (66.3)

110 (69.2)

 

    Yes

115 (33.7)

49 (30.8)

 

  Regular aspirin or NSAIDs use (n = 511)

  

0.736

    No

290 (83.1)

130 (80.2)

 

    Yes

59 (16.9)

32 (19.8)

 

Lesion factors

  Location

  

0.002

    Proximal

238 (64.3)

81 (50.0)

 

    Distal

132 (35.7)

81 (50.0)

 

  Location (Subsites)

  

0.004

    Cecum

41 (11.1)

12 (7.4)

 

    Ascending colon

124 (33.5)

47 (29.0)

 

    Transverse colon

73 (19.7)

22 (13.6)

 

    Descending colon

30 (8.1)

8 (4.9)

 

    Sigmoid colon

72 (19.5)

47 (29.0)

 

    Rectum

30 (8.1)

26 (16.0)

 

    Size (mm) [mean ± SD] (range)

10.6 ± 7.4 (2.0–40.0)

10.9 ± 7.6 (2.0–50.0)

0.625

    Proximal colon

11.4 ± 7.3

10.9 ± 7.6

0.350

    Distal colon

9.2 ± 7.5

11.0 ± 7.6

0.825

  Size (mm) [mean ± SD] (range) (Subsites)

    Cecum

10.6 ± 7.9

13.2 ± 10.0

0.717

    Ascending colon

11.9 ± 6.7

10.4 ± 5.6

0.189

    Transverse colon

11.0 ± 7.8

10.9 ± 9.7

0.872

    Descending colon

9.4 ± 7.3

9.1 ± 4.8

0.486

    Sigmoid colon

9.4 ± 7.8

10.7 ± 8.5

0.817

    Rectum

8.6 ± 6.9

12.1 ± 6.8

0.615

  Morphology (Paris classification)

  

<0.001

    0-Ip

25 (6.8)

27 (16.7)

 

    0-Isp

47 (12.7)

29 (17.9)

 

    0-Is

169 (45.7)

65 (40.1)

 

    0-IIa

119 (32.2)

32 (19.8)

 

    0-IIb

2 (0.5)

3 (1.9)

 

    0-IIa + IIc

8 (2.2)

6 (3.7)

 

  Endoscopic features

    Nodular surface

127 (34.3)

117 (72.2)

<0.001

    Disrupted vascular pattern

147 (39.7)

85 (52.5)

0.006

    Altered fold contour

100 (27.0)

41 (25.3)

0.679

    Dome-shaped morphology

98 (26.5)

37 (23.0)

0.394

    Pale color

82 (23.2)

29 (17.9)

0.168

    Mucus cap

46 (12.4)

16 (9.9)

0.398

    Rim of debris/bubbles

28 (7.6)

4 (2.5)

0.023

  Associated lesions

    TSA

26 (7.0)

4 (2.5)

0.036

    Hyperplastic polyp

96 (25.9)

33 (20.4)

0.167

    Conventional adenoma with LGD

126 (34.1)

84 (51.9)

<0.001

    Conventional adenoma with HGD + ADC

26 (7.0)

19 (11.7)

0.090

    Advanced adenoma

37 (10.0)

20 (12.3)

0.421

Procedure factors

  Removal method

  

0.001

    Polypectomy

82 (22.2)

13 (8.0)

 

    EMR

271 (73.2)

141 (87.0)

 

    EPMR

4 (1.1)

1 (0.6)

 

    ESD

13 (3.5)

7 (4.3)

 

  Post-procedural complication

  

0.006

    Bleeding

15 (4.1)

18 (11.2)

 

    Perforation

2 (0.5)

0 (0.0)

 
  1. SD, standard deviation; SSA/POs, SSA/Ps without dysplasia; SSA/PDAs, SSA/Ps with dysplasia or adenocarcinoma; BMI, body mass index; NSAIDs, nonsteroidal anti-inflammatory drugs; TSA, traditional serrated adenoma; LGD, low-grade dysplasia; HGD, high-grade dysplasia; ADC, adenocarcinoma; EMR, endoscopic mucosal resection; EPMR, endoscopic piecemeal mucosal resection; ESD, endoscopic submucosal dissection.